Published in J Immunol on October 15, 1993
Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal (2012) 2.13
CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression. Cancer Res (2010) 2.13
Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells. J Cell Biol (1997) 1.46
CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73. J Exp Med (1995) 1.37
CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes. J Immunol (2008) 1.18
Identification of a novel human memory T-cell population with the characteristics of stem-like chemo-resistance. Oncoimmunology (2016) 0.79
Mammalian telomeres end in a large duplex loop. Cell (1999) 12.12
Prediction of difficult mask ventilation. Anesthesiology (2000) 8.31
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia (2006) 5.64
Control of human telomere length by TRF1 and TRF2. Mol Cell Biol (2000) 4.54
A common receptor protein for phage T5 and colicin M in the outer membrane of Escherichia coli B. Biochim Biophys Acta (1973) 4.18
The murein-lipoprotein linkage in the cell wall of Escherichia coli. Eur J Biochem (1970) 3.63
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med (1997) 2.73
Mapping of genes predisposing to idiopathic generalized epilepsy. Hum Mol Genet (1995) 2.65
Intestinal loop lengthening--a technique for increasing small intestinal length. J Pediatr Surg (1980) 2.62
Supramolecular structure of the rigid layer of the cell wall of Salmonella, Serratia, Proteus, and Pseudomonas fluorescens. Number of lipoprotein molecules in a membrane layer. Biochemistry (1970) 2.55
Ecto-enzyme and signaling functions of lymphocyte CD73. Immunol Rev (1998) 2.46
Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1. Nat Neurosci (2002) 2.43
Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst (1996) 2.28
New obesity body mass index threshold for self-reported data. J Epidemiol Community Health (2008) 2.10
Mutations in ribosomal protein S19 gene and diamond blackfan anemia: wide variations in phenotypic expression. Blood (1999) 2.07
Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nat Immunol (2001) 1.91
Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides. J Clin Invest (1998) 1.86
Circumumbilical incision for pyloromyotomy. Br J Surg (1986) 1.78
Characterization of the receptor protein for phage T5 and colicin M in the outer membrane of E. coli B. FEBS Lett (1973) 1.78
Comparison of phenotypical and molecular methods for the identification of bacterial strains isolated from a deep subsurface environment. Appl Environ Microbiol (1995) 1.75
Surface expression, polarization, and functional significance of CD73 in human intestinal epithelia. J Clin Invest (1997) 1.75
TRF1 promotes parallel pairing of telomeric tracts in vitro. J Mol Biol (1998) 1.73
Multicenter evaluation of the fully automated COBAS AMPLICOR PCR test for detection of Chlamydia trachomatis in urogenital specimens. J Clin Microbiol (1999) 1.71
Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis. Stroke (2001) 1.66
Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation. J Neurosci (2001) 1.62
Tolciclate against dermatophytes. Arzneimittelforschung (1976) 1.62
Genome search for susceptibility loci of common idiopathic generalised epilepsies. Hum Mol Genet (2000) 1.61
Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6 beta-hydroxylase cytochrome P-450 enzyme. Arch Biochem Biophys (1988) 1.58
Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet (1989) 1.57
Comparison of two methods of processing induced sputum: selected versus entire sputum. Am J Respir Crit Care Med (1998) 1.56
Attachment of lipoprotein to murein (peptidoglycan) of Escherichia coli in the presence and absence of penicillin FL 1060. J Bacteriol (1975) 1.56
Detection of hyperreactive T cells in multiple myeloma by multivalent cross-linking of the CD3/TCR complex. Blood (1991) 1.56
SCID: the role of adenosine deaminase deficiency. Immunol Today (1997) 1.55
In vitro inactivation of Chlamydia trachomatis and of a panel of DNA (HSV-2, CMV, adenovirus, BK virus) and RNA (RSV, enterovirus) viruses by the spermicide benzalkonium chloride. J Antimicrob Chemother (2000) 1.52
Hodgkin's lymphoma: the pathologist's viewpoint. J Clin Pathol (2002) 1.51
Waardenburg's syndrome associated with total aganglionosis. Arch Dis Child (1983) 1.46
Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy. Neurology (2003) 1.45
Investigation of the male pattern baldness major genetic susceptibility loci AR/EDA2R and 20p11 in female pattern hair loss. Br J Dermatol (2012) 1.44
Interaction between endothelium and CD4+CD45RA+ lymphocytes. Role of the human CD38 molecule. J Immunol (1994) 1.44
Fever and neutropenia in children with cancer: a therapeutic approach related to the underlying disease. Pediatr Infect Dis J (1993) 1.43
[Anaesthetic preoperative assessment of chronic medications and herbal medicine use: a multicenter survey]. Ann Fr Anesth Reanim (2006) 1.41
The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy. Br J Radiol (2014) 1.41
Induced sputum cellularity. Reference values and distribution in normal volunteers. Am J Respir Crit Care Med (2000) 1.40
[Model of a uniform system for surgical statistics and quality assurance in surgery]. Zentralbl Chir (1987) 1.40
Adenosine deaminase deficiency and severe combined immunodeficiency disease. Adv Enzymol Relat Areas Mol Biol (1980) 1.39
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy. Haematologica (1999) 1.39
Pyrimidine 5'-nucleotidase acquired deficiency in beta-thalassemia: involvement of enzyme-SH groups in the inactivation process. Acta Haematol (1989) 1.39
[Intuition in surgery]. Zentralbl Chir (1999) 1.39
Implantation of a central venous access device. J R Coll Surg Edinb (1990) 1.38
Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet (1988) 1.35
C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system. Blood (1992) 1.33
Indications for pediatric intestinal transplantation: a position paper of the American Society of Transplantation. Pediatr Transplant (2001) 1.32
X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat Genet (1995) 1.29
CD73 expression and fyn-dependent signaling on murine lymphocytes. Eur J Immunol (1998) 1.28
P-selectin (CD62) binds to subpopulations of human memory T lymphocytes and natural killer cells. Biochem Biophys Res Commun (1992) 1.26
Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells. J Clin Oncol (1999) 1.26
A Xenopus egg factor with DNA-binding properties characteristic of terminus-specific telomeric proteins. Genes Dev (1993) 1.25
Male urethritis with and without discharge: a clinical and microbiological study. Sex Transm Dis (1995) 1.25
The contemporary outcome of gastroschisis. J Pediatr Surg (2000) 1.23
Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-kappa B pathway. FEBS Lett (2002) 1.21
Enumeration of viable bacteria in the marine pelagic environment. Appl Environ Microbiol (1996) 1.19
Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft. Bone Marrow Transplant (2000) 1.19
T gamma cells express T lymphocyte-associated antigens. J Immunol (1981) 1.17
Bacterial diversity in a deep-subsurface clay environment. Appl Environ Microbiol (1996) 1.16
Alterations in smooth muscle contractile and cytoskeleton proteins and interstitial cells of Cajal in megacystis microcolon intestinal hypoperistalsis syndrome. J Pediatr Surg (2003) 1.15
Familial tumoral calcinosis and testicular microlithiasis associated with a new mutation of GALNT3 in a white family. J Clin Pathol (2006) 1.15
In-vitro activity of azithromycin against Chlamydia trachomatis. J Antimicrob Chemother (1990) 1.15
Hernia through iliac crest defects. A report of four cases. Int Orthop (1995) 1.14
Immunological analysis of acetyl-CoA carboxylase mass, tissue distribution and subunit composition. Biochem J (1990) 1.12
Screening of Chlamydia trachomatis genital infection in a young Parisian population. Sex Transm Infect (1999) 1.12
Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy. Br J Haematol (1984) 1.12
Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation. Blood (1997) 1.10
Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma. Haematologica (2001) 1.10
Purification of 5'-nucleotidase from human placenta after release from plasma membranes by phosphatidylinositol-specific phospholipase C. Biochem Biophys Res Commun (1987) 1.10
Ecto-5'-nucleotidase expression during human B cell development. An explanation for the heterogeneity in B lymphocyte ecto-5'-nucleotidase activity in patients with hypogammaglobulinemia. J Immunol (1986) 1.10
Isoform-specific associations of CD45 with accessory molecules in human T lymphocytes. Eur J Immunol (1992) 1.09
Phenotype and function of engrafted maternal T cells in patients with severe combined immunodeficiency. J Immunol (1984) 1.08
Ecto-5'-nucleotidase activity in T and B lymphocytes from normal subjects and patients with congenital X-linked agammaglobulinemia. J Immunol (1979) 1.07
Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers. Leukemia (2000) 1.06
Metastatic lymph node ratio versus number of metastatic lymph nodes as a prognostic factor in gastric cancer. Eur J Surg Oncol (2012) 1.06
Comparative screening of plant essential oils: phenylpropanoid moiety as basic core for antiplatelet activity. Life Sci (2005) 1.05
Evaluation by multidimensional instruments of health-related quality of life of elderly cancer patients undergoing three different "psychosocial" treatment approaches. A randomized clinical trial. Support Care Cancer (1996) 1.04
Comparison of methods to enumerate white blood cells in semen. Fertil Steril (1993) 1.03
Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood (2000) 1.03
Single nucleotide polymorphism in prohibitin 3' untranslated region and breast-cancer susceptibility. Lancet (2001) 1.02
Alterations of the p53 tumor suppressor gene during mouse skin tumor progression. Cancer Res (1991) 1.02
Interrelationships among arenaviruses measured by indirect immunofluorescence. Intervirology (1978) 1.02
Recombinant interferon alfa-2b (Intron A) as post-induction therapy for responding multiple myeloma patients. M84 protocol. Cancer Treat Rev (1988) 1.02